Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal

Fundamental&Clinical Pharmacology, EarlyView.

Source: Fundamental and Clinical Pharmacology - May 30, 2018 Category: Drugs & Pharmacology Authors: Lei Chen , Hongwen Cao , Chao Yu , Yigeng Feng Source Type: research